Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 19 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

42%

8 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 3
6(33.3%)
Phase 2
6(33.3%)
Phase 1
4(22.2%)
Phase 4
2(11.1%)
18Total
Phase 3(6)
Phase 2(6)
Phase 1(4)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (19)

Showing 19 of 19 trials
NCT07310173Phase 2Recruiting

Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma

Role: lead

NCT07092748Phase 1Recruiting

A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors

Role: lead

NCT06107790Phase 3Completed

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast Cancer

Role: lead

NCT06048224Phase 3Completed

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of Recombinant Anti-interleukin-6 Receptor Humanized Monoclonal Antibody Injection in Combination With Methotrexate and Jamelor ® in the Treatment of Moderate to Severe Rheumatoid Arthritis

Role: lead

NCT05058352Phase 1Unknown

A Study of HS269 in Patients With Advanced Solid Tumors

Role: lead

NCT04425460Phase 3Unknown

A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19

Role: lead

NCT03625401Phase 2Unknown

Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease

Role: lead

NCT03790982Phase 2Unknown

Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease

Role: lead

NCT03757754Phase 1Unknown

HPPH Photodynamic Therapy for Patients With Esophageal Cancer

Role: lead

NCT03755258Phase 1Unknown

Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis

Role: lead

NCT03413462Phase 3Completed

Efficacy and Safety Study of HS-25 in Chinese Adults With Primary Hypercholesterolemia

Role: lead

NCT03464682Phase 3Unknown

Efficacy and Safety of HS-25 or in Combination With Atorvastatin in Chinese Adults With Primary Hypercholesterolemia

Role: lead

NCT03433196Phase 3Completed

Efficacy and Safety Study of the HS-25 Combination With Atorvastatin in Subjects With Hypercholesterolemia in Coronary Heart Diseases

Role: lead

NCT03636984Unknown

Efficacy and Safety Study of Anbainuo in Chinese Patients With RA/AS in the Real World

Role: lead

NCT03485118Phase 2Completed

RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Role: lead

NCT02087917Phase 2Completed

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

Role: lead

NCT02191475Phase 2Unknown

Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock

Role: collaborator

NCT02024295Phase 4Unknown

Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis

Role: lead

NCT01998620Phase 4Unknown

Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis

Role: lead

All 19 trials loaded